337 related articles for article (PubMed ID: 23481210)
1. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
Vicha A; Musil Z; Pacak K
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
[TBL] [Abstract][Full Text] [Related]
2. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
[TBL] [Abstract][Full Text] [Related]
3. Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.
López-Jiménez E; Gómez-López G; Leandro-García LJ; Muñoz I; Schiavi F; Montero-Conde C; de Cubas AA; Ramires R; Landa I; Leskelä S; Maliszewska A; Inglada-Pérez L; de la Vega L; Rodríguez-Antona C; Letón R; Bernal C; de Campos JM; Diez-Tascón C; Fraga MF; Boullosa C; Pisano DG; Opocher G; Robledo M; Cascón A
Mol Endocrinol; 2010 Dec; 24(12):2382-91. PubMed ID: 20980436
[TBL] [Abstract][Full Text] [Related]
4. Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
Imperiale A; Moussallieh FM; Roche P; Battini S; Cicek AE; Sebag F; Brunaud L; Barlier A; Elbayed K; Loundou A; Bachellier P; Goichot B; Stratakis CA; Pacak K; Namer IJ; Taïeb D
Neoplasia; 2015 Jan; 17(1):55-65. PubMed ID: 25622899
[TBL] [Abstract][Full Text] [Related]
5. Hereditary Diseases Predisposing to Pheochromocytoma (VHL, NF-1, Paraganglioma Syndromes, and Novel Genes).
Sarkadi B; Patócs A
Exp Suppl; 2019; 111():129-147. PubMed ID: 31588531
[TBL] [Abstract][Full Text] [Related]
6. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
7. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
8. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.
Rattenberry E; Vialard L; Yeung A; Bair H; McKay K; Jafri M; Canham N; Cole TR; Denes J; Hodgson SV; Irving R; Izatt L; Korbonits M; Kumar AV; Lalloo F; Morrison PJ; Woodward ER; Macdonald F; Wallis Y; Maher ER
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1248-56. PubMed ID: 23666964
[TBL] [Abstract][Full Text] [Related]
10. Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
Flynn A; Dwight T; Harris J; Benn D; Zhou L; Hogg A; Catchpoole D; James P; Duncan EL; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
J Clin Endocrinol Metab; 2016 Mar; 101(3):1034-43. PubMed ID: 26796762
[TBL] [Abstract][Full Text] [Related]
11. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.
Jochmanová I; Yang C; Zhuang Z; Pacak K
J Natl Cancer Inst; 2013 Sep; 105(17):1270-83. PubMed ID: 23940289
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
[TBL] [Abstract][Full Text] [Related]
15. [Genetics of paragangliomas and pheochromocytomas].
Favier J; Gimenez-Roqueplo AP
Med Sci (Paris); 2012; 28(6-7):625-32. PubMed ID: 22805139
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing in pheochromocytoma or functional paraganglioma.
Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
[TBL] [Abstract][Full Text] [Related]
18. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
[TBL] [Abstract][Full Text] [Related]
19. Mutation screening in a Norwegian cohort with pheochromocytoma.
Sjursen W; Halvorsen H; Hofsli E; Bachke S; Berge A; Engebretsen LF; Falkmer SE; Falkmer UG; Varhaug JE
Fam Cancer; 2013 Sep; 12(3):529-35. PubMed ID: 23407919
[TBL] [Abstract][Full Text] [Related]
20. Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.
Vicha A; Taieb D; Pacak K
Endocr Relat Cancer; 2014 Jun; 21(3):R261-77. PubMed ID: 24500761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]